跳至主要内容
临床试验/RBR-4rxr2c
RBR-4rxr2c进行中(未招募)未知

Gabapentin versus dexclorfeniramine in the treatment of uremic pruritus in hemodialysis patients: a randomized clinical trial, double-blind and controlled

Faculdade de Medicina de Botucatu0 个研究点开始时间: 2016年7月11日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 —(—)

入选标准

  • Sign the consent form; Age above 18 years, of both genders; chronic renal insufficiency stage 5 on hemodialysis for at least 3 months; persistent pruritus of any intensity that occurs at least three times per week with a duration of 30 days or more; no use of topical antipruritic medications and / or systemic at least one week before start of study

排除标准

  • Chronic skin diseases (allergic, infectious and parasitic); Chronic liver disease; Internal malignant disease; Use of opioids, antihistamines or corticosteroids.
  • the participants Will be discontinued if: withdrawal of consent; using other treatments for pruritus not recommended in this protocol and serious adverse events

研究者

发起方
Faculdade de Medicina de Botucatu

相似试验